Kumquat Biosciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$30M
- Investors
-
7
Kumquat Biosciences General Information
Description
Developer of medical therapies designed to help in the discovery of oncology medicines. The company's therapies offer medicines by combining internal expertise in drug discovery and development with external collaboration in academics, enabling cancer patients to bring sustainable and life-changing benefits.
Contact Information
Website
www.kumquatbiosciences.comCorporate Office
- 10770 Wateridge Circle
- Suite 120
- San Diego, CA 92121
- United States
Corporate Office
- 10770 Wateridge Circle
- Suite 120
- San Diego, CA 92121
- United States
Kumquat Biosciences Timeline
Kumquat Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A2) | 16-Aug-2021 | $30M | Completed | Pre-Clinical Trials | ||
| 2. Early Stage VC (Series A1) | 16-Feb-2021 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC (Series A) | 08-Sep-2019 | $55.9M | $55.9M | Completed | Startup |
Kumquat Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 20,489,018 | $0.001000 | $2.73 | $2.73 | 1x | $2.73 | 44.07% |
Kumquat Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kumquat Biosciences Patents
Kumquat Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240294531-A1 | Covalent heterocycles and uses thereof | Inactive | 23-Dec-2022 | ||
| US-20240226113-A1 | Heterocyclic compounds and uses thereof | Active | 05-Aug-2022 | ||
| US-12059425-B2 | Heterocyclic compounds and uses thereof | Active | 05-Aug-2022 | ||
| US-20240270736-A1 | Macrocyclic heterocycles and uses thereof | Inactive | 10-Jun-2022 | ||
| US-20240109918-A1 | Heterocyclic compounds and uses thereof | Pending | 04-May-2022 | C07D519/00 |
Kumquat Biosciences Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Carin Sandvik | Vice President, Finance | |
| Yi Liu Ph.D | Co-Founder, Chief Executive Officer & Board Member | |
| Pingda Ren Ph.D | Co-Founder, Chief Operating Officer, and President | |
| Karen Wong JD | Co-Founder, General Counsel & Chief Business Officer |
Kumquat Biosciences Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Carl Gordon Ph.D | OrbiMed | Board Member | |
| Guoyao Xia Ph.D | Self | Board Observer | |
| Lynn Yang | HongShan | Board Member | |
| Nisha Marathe Ph.D | Roche Venture Fund | Board Observer | |
| Scott Platshon | Self | Board Member |
Kumquat Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kumquat Biosciences Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sequoia Capital | Venture Capital | Minority | ||
| Codon Capital | Venture Capital | Minority | ||
| EcoR1 Capital | Venture Capital | Minority | ||
| HongShan | Venture Capital | Minority | ||
| Lilly Asia Ventures | Corporate Venture Capital | Minority |
Kumquat Biosciences FAQs
-
When was Kumquat Biosciences founded?
Kumquat Biosciences was founded in 2019.
-
Who is the founder of Kumquat Biosciences?
Yi Liu Ph.D, Pingda Ren Ph.D, and Karen Wong JD are the founders of Kumquat Biosciences.
-
Who is the CEO of Kumquat Biosciences?
Yi Liu Ph.D is the CEO of Kumquat Biosciences.
-
Where is Kumquat Biosciences headquartered?
Kumquat Biosciences is headquartered in San Diego, CA.
-
What is the size of Kumquat Biosciences?
Kumquat Biosciences has 45 total employees.
-
What industry is Kumquat Biosciences in?
Kumquat Biosciences’s primary industry is Drug Discovery.
-
Is Kumquat Biosciences a private or public company?
Kumquat Biosciences is a Private company.
-
What is the current valuation of Kumquat Biosciences?
The current valuation of Kumquat Biosciences is .
-
What is Kumquat Biosciences’s current revenue?
The current revenue for Kumquat Biosciences is .
-
How much funding has Kumquat Biosciences raised over time?
Kumquat Biosciences has raised $136M.
-
Who are Kumquat Biosciences’s investors?
Sequoia Capital, Codon Capital, EcoR1 Capital, HongShan, and Lilly Asia Ventures are 5 of 7 investors who have invested in Kumquat Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
